Stock MDT MEDTRONIC PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-23 pm EDT 		5-day change 1st Jan Change
81.38 USD -5.11% Intraday chart for Medtronic plc -3.94% -1.21%
May. 23 News Highlights : Top Company News of the Day - Thursday at 5 PM ET DJ
May. 23 Sector Update: Health Care Stocks Retreat Late Afternoon MT

Valuation

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 117,150 131,390 176,867 143,746 121,002 113,874 - -
Enterprise Value (EV) 1 132,626 152,047 199,663 164,146 143,823 129,621 134,991 133,580
P/E ratio 25.6 x 27.7 x 49.3 x 28.7 x 32.3 x 28.9 x 21.2 x 19.5 x
Yield 2.29% 2.37% 1.77% 2.54% 2.99% 3.51% 3.37% 3.54%
Capitalization / Revenue 3.83 x 4.54 x 5.87 x 4.54 x 3.87 x 3.27 x 3.39 x 3.23 x
EV / Revenue 4.34 x 5.26 x 6.63 x 5.18 x 4.61 x 4.01 x 4.02 x 3.79 x
EV / EBITDA 13.6 x 17.9 x 24.7 x 16.7 x 15.5 x 14.8 x 14 x 12.9 x
EV / FCF 22.6 x 25.3 x 40.9 x 27.5 x 31.4 x 24.9 x 23 x 19.5 x
FCF Yield 4.43% 3.96% 2.45% 3.64% 3.18% 4.01% 4.35% 5.12%
Price to Book 2.35 x 2.59 x 3.43 x 2.71 x 2.35 x 2.08 x 2.16 x 2.1 x
Nbr of stocks (in thousands) 1,341,151 1,340,166 1,348,073 1,341,539 1,330,424 1,327,823 - -
Reference price 2 87.35 98.04 131.2 107.2 90.95 85.76 85.76 85.76
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 5/23/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Aprile 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 30,557 28,913 30,117 31,686 31,227 32,364 33,553 35,233
EBITDA 1 9,767 8,472 8,096 9,830 9,294 9,176 9,641 10,343
EBIT 1 8,872 7,565 7,177 8,856 8,295 8,272 8,688 9,306
Operating Margin 29.03% 26.16% 23.83% 27.95% 26.56% 25.56% 25.89% 26.41%
Earnings before Tax (EBT) 1 5,197 4,055 3,895 5,517 5,364 4,837 6,245 6,701
Net income 1 4,631 4,789 3,606 5,039 3,758 3,676 5,245 5,704
Net margin 15.16% 16.56% 11.97% 15.9% 12.03% 11.36% 15.63% 16.19%
EPS 2 3.410 3.540 2.660 3.730 2.820 2.760 4.047 4.405
Free Cash Flow 1 5,873 6,021 4,885 5,978 4,580 5,200 5,874 6,845
FCF margin 19.22% 20.82% 16.22% 18.87% 14.67% 16.07% 17.51% 19.43%
FCF Conversion (EBITDA) 60.13% 71.07% 60.34% 60.81% 49.28% 61.84% 60.92% 66.18%
FCF Conversion (Net income) 126.82% 125.73% 135.47% 118.63% 121.87% 141.46% 112% 120%
Dividend per Share 2 2.000 2.320 2.320 2.720 2.720 2.800 2.894 3.037
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 5/23/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 7,847 7,763 8,089 7,371 7,585 7,727 8,544 7,702 7,984 8,089 8,589 7,984 8,287 8,418 8,864
EBITDA 1 2,361 2,421 2,655 2,010 2,275 2,255 2,768 2,152 2,256 2,691 2,582 2,142 2,231 2,406 2,740
EBIT 1 2,116 2,181 2,402 1,765 2,020 1,998 2,512 1,909 2,009 2,042 2,311 1,941 2,048 2,180 2,514
Operating Margin 26.97% 28.09% 29.69% 23.95% 26.63% 25.86% 29.4% 24.79% 25.16% 25.24% 26.91% 24.31% 24.71% 25.89% 28.37%
Earnings before Tax (EBT) 1 - 1,589 1,602 1,044 1,395 1,375 1,551 1,196 1,313 1,472 856 1,233 1,392 1,431 1,743
Net income 1 1,311 1,480 1,485 929 427 1,222 1,179 791 909 1,322 654 1,164 1,268 1,330 1,578
Net margin 16.71% 19.06% 18.36% 12.6% 5.63% 15.81% 13.8% 10.27% 11.39% 16.34% 7.61% 14.58% 15.3% 15.81% 17.81%
EPS 2 0.9700 1.100 1.100 0.7000 0.3200 0.9200 0.8800 0.5900 0.6800 0.9900 0.4900 0.8860 0.9577 1.002 1.184
Dividend per Share 2 0.6300 0.6300 0.6800 0.6800 0.6800 0.6800 0.6800 0.6900 0.6900 0.6800 0.7000 0.7171 0.7170 0.7169 0.7146
Announcement Date 11/23/21 2/22/22 5/26/22 8/23/22 11/22/22 2/21/23 5/25/23 8/22/23 11/21/23 2/20/24 5/23/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 15,476 20,657 22,796 20,400 22,821 23,740 21,117 19,706
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.585 x 2.438 x 2.816 x 2.075 x 2.455 x 2.42 x 2.19 x 1.905 x
Free Cash Flow 1 5,873 6,021 4,885 5,978 4,580 5,200 5,874 6,845
ROE (net income / shareholders' equity) 14.1% 12.3% 11.8% 14.4% 13.5% 13.6% 13.6% 14.2%
ROA (Net income/ Total Assets) 7.83% 6.88% 6.54% 5.48% 7.74% 7.65% 6.81% 7.36%
Assets 1 59,149 69,598 55,178 92,031 48,523 48,070 77,053 77,523
Book Value Per Share 2 37.20 37.80 38.20 39.50 38.70 38.30 39.80 40.80
Cash Flow per Share 2 5.160 5.350 4.610 5.440 4.530 5.100 6.410 6.990
Capex 1 1,134 1,213 1,355 1,368 1,459 1,587 1,610 1,683
Capex / Sales 3.71% 4.2% 4.5% 4.32% 4.67% 4.9% 4.8% 4.78%
Announcement Date 5/23/19 5/21/20 5/27/21 5/26/22 5/25/23 5/23/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
85.76 USD
Average target price
94.7 USD
Spread / Average Target
+10.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
MEDTRONIC PLC Stock Medtronic plc
-1.21% 114B
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 182B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.53% 67.76B
DEXCOM, INC. Stock DexCom, Inc.
+1.22% 51.91B
CENCORA, INC. Stock Cencora, Inc.
+7.03% 43.23B
HOYA CORPORATION Stock Hoya Corporation
+6.07% 41.07B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+21.96% 32.07B
TERUMO CORPORATION Stock Terumo Corporation
+15.86% 25B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-4.81% 24.55B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.68% 24.35B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. Financials Medtronic plc